Author: admin
JACC: CardioOncology
There are no upcoming events at this time.
Life After Surviving Cancer: The Relief, Challenges And New Fears
Eighteen-year-old cancer patient Patrick McGill lies in his hospital bed while receiving IV chemotherapy treatment for a rare form of cancer at the UCSF Comprehensive Cancer Center Childrens Hospital Aug. 18, 2005 in San Francisco, Calif. (Justin Sullivan/Getty Images)
Argentina
ArgentinaArgentinaArgentinaArgentinaArgentinaArgentina
Cardio-Oncology: New field booms, but awareness lags
Open a PDF file Cardio-Oncology: New field booms, but awareness lags.
First Cardio-Oncology Society established on the continent of Africa
Over the summer, we are thrilled to announce, the first Cardio-Oncology Society on the continent of Africa was organized! The Cardio-Oncology Society of Southern Africa (COSOSA) was organized by Drs. YT (Trishun) Singh, Ines Buccimazza, and Ria David. COSOSA has been registered as a nonprofit organization and they report, “There is a great need for such a Cardio-Oncology Society in the African Continent, as the two main drivers of mortality, in Southern Africa are, cancer related disease and…cardiovascular and cerebrovascular disease….COSOSA is actively involved in attracting Cardiologists and Oncologists, to play an active role in the society.” The leaders of the new society explain, “We desperately need to collaborate with established Cardio-Oncology centers that already have international recognition, like ICOS. COSOSA is hosting its inaugural meeting on Saturday 7th March, 2020 in Durban.” ICOS Board President, Daniel Lenihan will be one of the keynote speakers.
This is another example of the kind of global development and collaboration that ICOS exists to promote. We wish this new chapter all the best as they begin their work and we look forward to working in close collaboration with them.
Welcome to the mid-year Cardio-Oncology newsletter for 2019!
So far, 2019 has been a successful year for Cardio-Oncology with submissions up 250% from 2018 and acceptances at an all-time high. In this newsletter, we will be delving further into these accomplishments as well as sharing journal metrics, highlighting well-performing articles, and exploring current developments with the journal.
Top Altmetric Attention Score of All Time
Altmetric scores track who is talking about published articles by collating online mentions and shares of an article on blogs, policy documents, mainstream media, social media, Wikipedia and others. The Altmetric Score represents a weighted approximation of online attention, based on the volume of mentions, the source of the mention and the authors.
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case seriesThis article currently has the highest Altmetric score out of all publications from the journal, placing it in the top 25% of all research outputs scored by Altmetric.
Submissions
Submissions to Cardio-Oncology have increased substantially in the first half of 2019. If the submissions stay consistent, the journal is on track for more than 40 submissions for 2019, over four times the amount received in 2018. Additionally, the journal has seen ten straight months of submissions, and is up 250% from this time last year.
The graphs below illustrate these trends, with all data from 2019 in navy.
Plans for PubMed Application
One of the major goals for Cardio-Oncology moving forward is to be indexed in PubMed. We hope to apply this September, as want to wait until the journal has had six months of continuous publication.
You can help us reach this goal by submitting your papers to Cardio-Oncology and encouraging your colleagues and peers to do so as well!